Study of the Oral Treatment MTR-601 in Cervical Dystonia
Public ClinicalTrials.gov record NCT06830642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Efficacy of MTR-601, a Novel Oral Treatment in Patients With Cervical Dystonia
Study identification
- NCT ID
- NCT06830642
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Motric Bio
- Industry
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- MTR-601 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2025
- Primary completion
- Jul 7, 2026
- Completion
- Aug 2, 2026
- Last update posted
- Dec 11, 2025
2025 – 2026
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Neuroscience Research, LLC | Phoenix | Arizona | 85032 | — |
| The Parkinson's and Movement Disorder Institute | Fountain Valley | California | 92708 | — |
| Keck Medicine of University of Southern California | Los Angeles | California | 90033 | — |
| CenExel Rocky Mountain Clinical Research | Englewood | Colorado | 80113 | — |
| Neurology One | Orlando | Florida | 32825 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| Emory University | Atlanta | Georgia | 30329 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Michigan State University, Department of Neurology | East Lansing | Michigan | 48824 | — |
| Quest Research Institute | Farmington Hills | Michigan | 48334 | — |
| University of New Mexico, The Nene and Jamie Koch Comprehensive Movement Disorder Clinic | Albuquerque | New Mexico | 87106 | — |
| Albany Medical Center Neurosciences Institute | Albany | New York | 12208 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Vanderbilt Neurology, The Vanderbilt Clinic | Nashville | Tennessee | 37232 | — |
| Kingfisher Cooperative, LLC | Spokane | Washington | 99201 | — |
| West Virginia University Medicine | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06830642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 11, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06830642 live on ClinicalTrials.gov.